Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Adlai Nortye Ltd. before investing.

In this article, we go over a few key elements for understanding Adlai Nortye Ltd.’s stock price such as:

• Adlai Nortye Ltd.’s current stock price and volume
• Why Adlai Nortye Ltd.’s stock price changed recently
• Upgrades and downgrades for ANL from analysts
• ANL’s stock price momentum as measured by its relative strength

About Adlai Nortye Ltd. (ANL)

Before we jump into Adlai Nortye Ltd.’s stock price, history, target price and what caused it to recently , let’s take a look at some background.

Adlai Nortye Ltd., a clinical-stage company, together with its subsidiaries, engages in the research and develops pharmaceutical products. Its product pipeline comprises AN0025, a small molecule EP4 antagonist which is in phase Ib and radiotherapy/chemoradiotherapy combination for the treatment of rectum cancer and esophageal cancer; and phase II trial for patients with moderate to high-risk rectal cancer. The company also develops AN9025, an oral small molecule pan-RAS(ON) inhibitor, which is in phase 1a clinical trials for the treatment of RAS-mutant cancers, including pancreatic, lung, and colorectal adenocarcinomas; AN4035, a proprietary CEACAM5-targeting antibody drug conjugate designed to deliver potent anti-tumor activity with an improved therapeutic window; and AN8025, a tri-specific antibody fusion protein which is in phase Ia clinical trial to treat advanced tumors. In addition, it develops AN4005, a small-molecule PD-L1 inhibitor that demonstrates antitumor activity by the blockade of PD-1/PD-L1 interaction which is in phase 1b clinical trial to activate cancer immunity. Further, the company is involved in technology transfer and consulting services business. Adlai Nortye Ltd. was founded in 2004 and is headquartered in North Brunswick, New Jersey.

Want to learn more about Adlai Nortye Ltd.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Adlai Nortye Ltd..

Adlai Nortye Ltd.’s Stock Price as of Market Close

As of July 31, 2026, 4:00 PM, CST, Adlai Nortye Ltd.’s stock price was $13.000.

Adlai Nortye Ltd. is 0% from its previous closing price of $13.000.

During the last market session, Adlai Nortye Ltd.’s stock traded between $12.465 and $13.280. Currently, there are approximately 31.99 million shares outstanding for Adlai Nortye Ltd..

Adlai Nortye Ltd.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

Adlai Nortye Ltd. Stock Price History

Adlai Nortye Ltd.’s (ANL) price is currently up 13.04% so far this month.

During the month of July, Adlai Nortye Ltd.’s stock price has reached a high of $13.500 and a low of $8.540.

Over the last year, Adlai Nortye Ltd. has hit prices as high as $17.250 and as low as $0.879. Year to date, Adlai Nortye Ltd.’s stock is up 815.49%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Adlai Nortye Ltd. Stock’s Price to ?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of July 31, 2026, there were analysts who downgraded Adlai Nortye Ltd.’s stock and analysts who upgraded over the last month.

Additionally, you'll want to evaluate Adlai Nortye Ltd.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Adlai Nortye Ltd.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Adlai Nortye Ltd. (ANL) by visiting AAII Stock Evaluator.

Relative Price Strength of Adlai Nortye Ltd.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of July 31, 2026, Adlai Nortye Ltd. has a weighted four-quarter relative price strength of 120.50%, which translates to a Momentum Score of 100 and is considered to be Very Strong.

Want to learn more about how Adlai Nortye Ltd. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Adlai Nortye Ltd. Stock Price: Bottom Line

As of July 31, 2026, Adlai Nortye Ltd.’s stock price is $13.000, which is 0% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Adlai Nortye Ltd. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.